A citation-based method for searching scientific literature

Christopher A Ross, Elizabeth H Aylward, Edward J Wild, Douglas R Langbehn, Jeffrey D Long, John H Warner, Rachael I Scahill, Blair R Leavitt, Julie C Stout, Jane S Paulsen, Ralf Reilmann, Paul G Unschuld, Alice Wexler, Russell L Margolis, Sarah J Tabrizi. Nat Rev Neurol 2014
Times Cited: 509







List of co-cited articles
680 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cerebral cortex structure in prodromal Huntington disease.
Peggy C Nopoulos, Elizabeth H Aylward, Christopher A Ross, Hans J Johnson, Vincent A Magnotta, Andrew R Juhl, Ronald K Pierson, James Mills, Douglas R Langbehn, Jane S Paulsen. Neurobiol Dis 2010
93
5

Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data.
Juan F Domínguez D, Julie C Stout, Govinda Poudel, Andrew Churchyard, Phyllis Chua, Gary F Egan, Nellie Georgiou-Karistianis. Br J Psychiatry 2016
23
21

Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy--results from the TRACK-HD study.
S J A van den Bogaard, E M Dumas, L Ferrarini, J Milles, M A van Buchem, J van der Grond, R A C Roos. J Neurol Sci 2011
45
11

Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease.
Emma M Coppen, Milou Jacobs, Annette A van den Berg-Huysmans, Jeroen van der Grond, Raymund A C Roos. Parkinsonism Relat Disord 2018
16
31

Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.
S E Browne, A C Bowling, U MacGarvey, M J Baik, S C Berger, M M Muqit, E D Bird, M F Beal. Ann Neurol 1997
628
5

Huntington disease.
J P Vonsattel, M DiFiglia. J Neuropathol Exp Neurol 1998
5

Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175.
Liliana B Menalled, Andrea E Kudwa, Sam Miller, Jon Fitzpatrick, Judy Watson-Johnson, Nicole Keating, Melinda Ruiz, Richard Mushlin, William Alosio, Kristi McConnell,[...]. PLoS One 2012
207
5

Design, Characterization, and Lead Selection of Therapeutic miRNAs Targeting Huntingtin for Development of Gene Therapy for Huntington's Disease.
Jana Miniarikova, Ilaria Zanella, Angelina Huseinovic, Tom van der Zon, Evelyn Hanemaaijer, Raygene Martier, Annemart Koornneef, Amber L Southwell, Michael R Hayden, Sander J van Deventer,[...]. Mol Ther Nucleic Acids 2016
55
9

Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients.
Edward J Wild, Roberto Boggio, Douglas Langbehn, Nicola Robertson, Salman Haider, James R C Miller, Henrik Zetterberg, Blair R Leavitt, Rainer Kuhn, Sarah J Tabrizi,[...]. J Clin Invest 2015
115
5

Potent and sustained huntingtin lowering via AAV5 encoding miRNA preserves striatal volume and cognitive function in a humanized mouse model of Huntington disease.
Nicholas S Caron, Amber L Southwell, Cynthia C Brouwers, Louisa Dal Cengio, Yuanyun Xie, Hailey Findlay Black, Lisa M Anderson, Seunghyun Ko, Xiang Zhu, Sander J van Deventer,[...]. Nucleic Acids Res 2020
17
29

Thalamic metabolism and symptom onset in preclinical Huntington's disease.
A Feigin, C Tang, Y Ma, P Mattis, D Zgaljardic, M Guttman, J S Paulsen, V Dhawan, D Eidelberg. Brain 2007
130
4

Striatal volume loss in HD as measured by MRI and the influence of CAG repeat.
H D Rosas, J Goodman, Y I Chen, B G Jenkins, D N Kennedy, N Makris, M Patti, L J Seidman, M F Beal, W J Koroshetz. Neurology 2001
102
4


Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.
Libin Cui, Hyunkyung Jeong, Fran Borovecki, Christopher N Parkhurst, Naoko Tanese, Dimitri Krainc. Cell 2006
736
4

Huntington's disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain.
U Rüb, K Seidel, H Heinsen, J P Vonsattel, W F den Dunnen, H W Korf. Brain Pathol 2016
57
7


Normal huntingtin function: an alternative approach to Huntington's disease.
Elena Cattaneo, Chiara Zuccato, Marzia Tartari. Nat Rev Neurosci 2005
426
4

Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice.
Austen J Milnerwood, Clare M Gladding, Mahmoud A Pouladi, Alexandra M Kaufman, Rochelle M Hines, Jamie D Boyd, Rebecca W Y Ko, Oana C Vasuta, Rona K Graham, Michael R Hayden,[...]. Neuron 2010
336
4

Functional and connectivity changes during working memory in Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.
Nellie Georgiou-Karistianis, Govinda R Poudel, Juan F Domínguez D, Rebecca Langmaid, Marcus A Gray, Andrew Churchyard, Phyllis Chua, Beth Borowsky, Gary F Egan, Julie C Stout. Brain Cogn 2013
41
9

Striatal volume contributes to the prediction of onset of Huntington disease in incident cases.
Elizabeth H Aylward, Dawei Liu, Peggy C Nopoulos, Christopher A Ross, Ronald K Pierson, James A Mills, Jeffrey D Long, Jane S Paulsen. Biol Psychiatry 2012
78
5

Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical "disconnection".
H Diana Rosas, Stephanie Y Lee, Alexander C Bender, Alexandra K Zaleta, Mark Vangel, Peng Yu, Bruce Fischl, Vasanth Pappu, Christina Onorato, Jang-Ho Cha,[...]. Neuroimage 2010
177
4

Corticostriatal synaptic adaptations in Huntington's disease.
Joshua L Plotkin, D James Surmeier. Curr Opin Neurobiol 2015
65
6

Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis.
H D Rosas, W J Koroshetz, Y I Chen, C Skeuse, M Vangel, M E Cudkowicz, K Caplan, K Marek, L J Seidman, N Makris,[...]. Neurology 2003
365
4

White matter connectivity reflects clinical and cognitive status in Huntington's disease.
Govinda R Poudel, Julie C Stout, Juan F Domínguez D, Louisa Salmon, Andrew Churchyard, Phyllis Chua, Nellie Georgiou-Karistianis, Gary F Egan. Neurobiol Dis 2014
62
6


Basal ganglia atrophy in prodromal Huntington's disease is detectable over one year using automated segmentation.
D S Adnan Majid, Adam R Aron, Wesley Thompson, Sarah Sheldon, Samar Hamza, Diederick Stoffers, Dominic Holland, Jody Goldstein, Jody Corey-Bloom, Anders M Dale. Mov Disord 2011
40
10

Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease.
Taneli Heikkinen, Kimmo Lehtimäki, Nina Vartiainen, Jukka Puoliväli, Susan J Hendricks, Jack R Glaser, Amyaouch Bradaia, Kristian Wadel, Chrystelle Touller, Outi Kontkanen,[...]. PLoS One 2012
136
4

Artificial miRNAs Reduce Human Mutant Huntingtin Throughout the Striatum in a Transgenic Sheep Model of Huntington's Disease.
Edith L Pfister, Natalie DiNardo, Erica Mondo, Florie Borel, Faith Conroy, Cara Fraser, Gwladys Gernoux, Xin Han, Danjing Hu, Emily Johnson,[...]. Hum Gene Ther 2018
38
10

Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington's disease.
Bryan Zeitler, Steven Froelich, Kimberly Marlen, David A Shivak, Qi Yu, Davis Li, Jocelynn R Pearl, Jeffrey C Miller, Lei Zhang, David E Paschon,[...]. Nat Med 2019
56
7

Therapeutic approaches to Huntington disease: from the bench to the clinic.
Nicholas S Caron, E Ray Dorsey, Michael R Hayden. Nat Rev Drug Discov 2018
53
7

CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion.
J-M Lee, E M Ramos, J-H Lee, T Gillis, J S Mysore, M R Hayden, S C Warby, P Morrison, M Nance, C A Ross,[...]. Neurology 2012
185
4

A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats.
B Kremer, P Goldberg, S E Andrew, J Theilmann, H Telenius, J Zeisler, F Squitieri, B Lin, A Bassett, E Almqvist. N Engl J Med 1994
417
4


Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic.
Jana Miniarikova, Melvin M Evers, Pavlina Konstantinova. Mol Ther 2018
19
21

Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.
Brinda Ravikumar, Coralie Vacher, Zdenek Berger, Janet E Davies, Shouqing Luo, Lourdes G Oroz, Francesco Scaravilli, Douglas F Easton, Rainer Duden, Cahir J O'Kane,[...]. Nat Genet 2004
4

Structural MRI in Huntington's disease and recommendations for its potential use in clinical trials.
Nellie Georgiou-Karistianis, Rachael Scahill, Sarah J Tabrizi, Ferdinando Squitieri, Elizabeth Aylward. Neurosci Biobehav Rev 2013
57
7

Reliability and factor structure of the Short Problem Behaviors Assessment for Huntington's disease (PBA-s) in the TRACK-HD and REGISTRY studies.
Jenny Callaghan, Cheryl Stopford, Natalie Arran, Marie-Francoise Boisse, Allison Coleman, Rachelle Dar Santos, Eve M Dumas, Ellen P Hart, Damian Justo, Gail Owen,[...]. J Neuropsychiatry Clin Neurosci 2015
41
9

Onset and rate of striatal atrophy in preclinical Huntington disease.
E H Aylward, B F Sparks, K M Field, V Yallapragada, B D Shpritz, A Rosenblatt, J Brandt, L M Gourley, K Liang, H Zhou,[...]. Neurology 2004
285
4

Automated differentiation of pre-diagnosis Huntington's disease from healthy control individuals based on quadratic discriminant analysis of the basal ganglia: the IMAGE-HD study.
N Georgiou-Karistianis, M A Gray, J F Domínguez D, A R Dymowski, I Bohanna, L A Johnston, A Churchyard, P Chua, J C Stout, G F Egan. Neurobiol Dis 2013
55
7

Emotion recognition in Huntington's disease: a systematic review.
Susie M D Henley, Marianne J U Novak, Chris Frost, John King, Sarah J Tabrizi, Jason D Warren. Neurosci Biobehav Rev 2012
64
6

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.
C Zuccato, A Ciammola, D Rigamonti, B R Leavitt, D Goffredo, L Conti, M E MacDonald, R M Friedlander, V Silani, M R Hayden,[...]. Science 2001
914
4

Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.
L A Raymond, V M André, C Cepeda, C M Gladding, A J Milnerwood, M S Levine. Neuroscience 2011
186
4

Depression in the early stages of Huntington disease.
Eric A Epping, Jane S Paulsen. Neurodegener Dis Manag 2011
42
9

The Neuropathology of Huntington's Disease.
Henry J Waldvogel, Eric H Kim, Lynette J Tippett, Jean-Paul G Vonsattel, Richard L M Faull. Curr Top Behav Neurosci 2015
71
5

Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study.
G Douaud, V Gaura, M-J Ribeiro, F Lethimonnier, R Maroy, C Verny, P Krystkowiak, P Damier, A-C Bachoud-Levi, P Hantraye,[...]. Neuroimage 2006
182
4

Early atrophy of pallidum and accumbens nucleus in Huntington's disease.
Simon J A van den Bogaard, Eve M Dumas, Tanka P Acharya, Hans Johnson, Douglas R Langbehn, Rachael I Scahill, Sarah J Tabrizi, Mark A van Buchem, Jeroen van der Grond, Raymund A C Roos. J Neurol 2011
81
4

Rate of functional decline in Huntington's disease. Huntington Study Group.
K Marder, H Zhao, R H Myers, M Cudkowicz, E Kayson, K Kieburtz, C Orme, J Paulsen, J B Penney, E Siemers,[...]. Neurology 2000
253
4

Social cognition in Huntington's disease: A meta-analysis.
Emre Bora, Dennis Velakoulis, Mark Walterfang. Behav Brain Res 2016
48
8

Motor, cognitive, and functional declines contribute to a single progressive factor in early HD.
Scott A Schobel, Giuseppe Palermo, Peggy Auinger, Jeffrey D Long, Shiyang Ma, Omar S Khwaja, Dylan Trundell, Merit Cudkowicz, Steven Hersch, Cristina Sampaio,[...]. Neurology 2017
43
9

Preparing for preventive clinical trials: the Predict-HD study.
Jane S Paulsen, Michael Hayden, Julie C Stout, Douglas R Langbehn, Elizabeth Aylward, Christopher A Ross, Mark Guttman, Martha Nance, Karl Kieburtz, David Oakes,[...]. Arch Neurol 2006
229
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.